World Pharma News / Search results for nplate

1
Vote

FDA Approves First Bone Marrow Stimulator to Treat Immune-Related Low Platelet Counts

Posted by worldpharmanews 568 days ago (http://www.worldpharmanews.com)
Category: Product | Tags: fda nplate romiplostim

The U.S. Food and Drug Administration approved Nplate (romiplostim), the first product that directly stimulates the bone marrow to produce needed platelets in patients with a rare blood disorder that read more »
Discuss Add this link to... Bury

1
Vote

European Commission (EC) has granted marketing authorisation for Nplate(R) (romiplostim)

Posted by worldpharmanews 400 days ago (http://www.worldpharmanews.com)
Category: Product | Tags: amgen nplate

Amgen (Nasdaq: AMGN) announced that the European Commission (EC) has granted marketing authorisation for Nplate(R) (romiplostim) for the treatment of splenectomised adult chronic immune (idiopathic) read more »
Discuss Add this link to... Bury

2
Vote

New Study Shows Nplate(R) Significantly Reduces Splenectomy Rate and Treatment Failure

Posted by worldpharmanews 280 days ago (http://www.worldpharmanews.com)
Category: Product | Tags: amgen nplate

Amgen Inc. (Nasdaq: AMGN) released the results of a new study comparing Nplate(R) (romiplostim) to the medical standard of care (SOC) in non-splenectomised adult patients with chronic immune thromboc read more »
Discuss Add this link to... Bury